Refractory Bladder Carcinoma
2 clinical trials · Condition
◉ Watch Refractory Bladder Carcinoma
| Record | Firm | Date |
|---|---|---|
| Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib (NCT05052372) | xCures | 2021-11-21 |
| Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy (NCT04502095) | Roswell Park Cancer Institute | 2020-09-02 |
Track Refractory Bladder Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.